Detalles de la búsqueda
1.
Interleukin-10 and Transforming Growth Factor-ß Cytokines Decrease Immune Activation During Normothermic Ex Vivo Machine Perfusion of the Rat Liver.
Liver Transpl;
27(11): 1577-1591, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34118129
2.
Treatment with the matricellular protein CCN3 blocks and/or reverses fibrosis development in obesity with diabetic nephropathy.
Am J Pathol;
184(11): 2908-21, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25193594
3.
CCN3 (NOV) is a negative regulator of CCN2 (CTGF) and a novel endogenous inhibitor of the fibrotic pathway in an in vitro model of renal disease.
Am J Pathol;
174(5): 1725-34, 2009 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-19359517
4.
Constitutive expression of E2F-1 leads to p21-dependent cell cycle arrest in S phase of the cell cycle.
Oncogene;
23(23): 4173-6, 2004 May 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-15048076
5.
Gadolinium-induced fibrosis is counter-regulated by CCN3 in human dermal fibroblasts: a model for potential treatment of nephrogenic systemic fibrosis.
J Cell Commun Signal;
6(2): 97-105, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22648571
6.
CCN3/CCN2 regulation and the fibrosis of diabetic renal disease.
J Cell Commun Signal;
4(1): 39-50, 2010 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-20195391
7.
TNF-alpha, but not IFN-gamma, regulates CCN2 (CTGF), collagen type I, and proliferation in mesangial cells: possible roles in the progression of renal fibrosis.
Am J Physiol Renal Physiol;
293(1): F157-65, 2007 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-17376761
Resultados
1 -
7
de 7
1
Próxima >
>>